This prospective descriptive-analytic study was conducted on pregnant women who were referred to the prenatal care clinic of Yas Hospital Complex affiliated with Tehran University of Medical Sciences, Tehran, Iran, in 2021 - 2022. Inclusion criteria were primiparous pregnant Iranian women referred for the first trimester (gestational age 11 to 13 weeks) screening test. Women having multiple pregnancies, a history of abortion, and abnormalities in their fetuses, as well as being unwilling to participate, were excluded from the study. Furthermore, the sample size was calculated as 151 according to PB prevalence (11.1%) reported in a previous study (
10), a confidence level of 95%, and an acceptable difference for PB prevalence (d) of 0.05. The formula used to calculate the sample size:
After assessing the pregnant women regarding inclusion and exclusion criteria, participants were selected through the convenience sampling method. The chosen women underwent a TVS device (Philips, Affinity 50, USA) with a 6 MHz probe to measure the cervical parameters: Length, Angle, and Width of the cervix. These parameters were first measured at 11 to 13 weeks, the second time at 18 - 20 weeks, and the third time at 28 - 30 weeks of gestational age. All TVS was done by one expert perinatology fellowship.
To measure the cervical length, the woman was placed in the lithotomy position with an empty bladder. The TVS probe was placed in the anterior fornix (without pressure on the cervix), and the length between the external OS triangle and V notch was measured as cervical length. The width of the cervix was measured at its midpoint. Uterocervical angle was defined as the angle between the line extending from the internal OS to the external OS and the parallel line of the lower segment of the uterus (
Figure 1). The measurement was repeated three times to minimize technical errors, and the mean values obtained were used for analysis.
Uterocervical angle (UCA) measurement
The mothers were followed up via phone once about two weeks after their delivery to check for any maternal or neonatal complications. The study outcomes included very preterm (defined as births between 28 weeks and < 32nd week of gestation) and late PB (defined as births between 32 weeks and < 37th week of gestation) (
26).
The data collection tool was a researcher-created Questionnaire. The variables of the study were maternal age and weight, placenta location, cervical parameters measurement, gestational ages at delivery time, the neonate weight, Apgar, and NICU hospitalization.
All analyses were performed using SPSS version 24 software, with a significance level set less than 0.05. Descriptive statistics, including mean, standard deviation, absolute, and relative frequency, were used to describe the data. The data were analyzed using the chi-square test or Fisher’s exact test for correlation between qualitative variables. According to the parametric or non-parametric distribution of numeric data (which was assessed with One-Sample Kolmogorov-Smirnov Test), the Independent Samples t-test or Mann-Whitney U in comparing two, and Repeated Measures or Friedman test in more than two variables were used. Receiver Operator Characteristic (ROC) curves were used to compare second and third UCA for prediction of PB incidence.
All participants gave oral and written informed consent and cooperated in the research. No additional costs were imposed on the subjects, and their right to stop participating was guaranteed. Ethical approval of the study was obtained from the Institutional Review Board of Tehran University of Medical Sciences (
IR.TUMS.MEDICINE.REC.1400.1022) based on the Declaration of Helsinki.